Ireland's vaccine rollout has gathered tremendous pace in the last few weeks as supply finally begins to meet demand.
Ireland is currently vaccinating at a faster pace than the US, the UK and a number of EU countries with jabs being rolled out in GP practices, mass vaccination centres and pharmacies.
Currently the portal for people aged between 25 and 29 can apply for a vaccine through the vaccination portal.
Meanwhile anyone aged 18 and over can apply to receive a Janssen vaccine through their local pharmacy.
The current aim is to have anyone who is eligible for a vaccine to be offered one by the end of August.
However with the spread of the Delta variant now posing the risk of another wave questions are mounting as to when the young population can get vaccinated including school children as the new school terms begins.
Here's what we know so far about the vaccinating of children:
This week it emerged the National Immunisation Advisory Group (NIAC) has now begun considering whether to recommend child vaccination for a number of weeks.
And speaking this week Paul Reid CEO of the HSE said: "First of all, we are waiting for recommendations from NIAC in terms of recommendations for 12 to 15-year-olds and how and when they should be administered,".
“Once we receive that advice, we will immediately put that into action – whether that is before schools return or post-schools return – we are looking at all options and from a HSE perspective, we will execute that once the advice comes.”
He said the infrastructure put in place for the Covid-19 vaccine rollout could be used to vaccinated children against other ailments.
“We are looking at our whole vaccination programme because, even beyond the COVID vaccines, there is a whole range of vaccines we want to administer during summer and post-summer as well in terms of younger people,” he said.
“So, we are looking at all options for the vaccination of younger people - including vaccination centres, pharmacies, schools programmes and GPs.
“We have a really good model running now and we are looking at all options to continue that down through the ages.”
The European Medicines Agency has already approved the use of the Pfizer/BioNTech vaccine for use on 12-15 year olds.
